Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile

Autor: Carlos Taxonera, Dolores Martín Arranz, Juan Luis Mendoza, José Lázaro Pérez-Calle, Fernando Bermejo, Concepción Núñez, Virginia Pascual, Javier P. Gisbert, María Gómez-García, Elena Urcelay, Javier Martín, Cristina González-Artacho, Luz Maria Medrano, Antonio López-Sanromán, Manuel Barreiro-de Acosta

Publikováno v: Mediators of Inflammation
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Mediators of Inflammation, Vol 2015 (2015)

Substantial proportion of Crohn’s disease (CD) patients shows no response or a limited response to treatment with infliximab (IFX) and to identify biomarkers of response would be of great clinical and economic benefit. The expression profile of fiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e0aee7ca9d1381fd527b680522a70d
https://doi.org/10.1155/2015/318207

Development and validation of a reversedphase liquid chromatography method for the evaluation of recombinant human interleukin- 11. Correlation with the bioassay

Autor: Souto, Ricardo Bizogne

Publikováno v: Biblioteca Digital de Teses e Dissertações do UFSM
Universidade Federal de Santa Maria (UFSM)
instacron:UFSM

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Interleukin 11 (IL-11) is a multifunctional cytokine in the IL-6 type family of long-chain helical cytokines, which modulates the proliferation, differentiation and maturation of various

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::e68ae7162e6f693bb7816a008ef2c4e0
http://repositorio.ufsm.br/handle/1/5925